Standard BioTools
IPOUnleashing tools to accelerate breakthroughs in human health
Public · South San Francisco, United States
- Headquarters
- South San Francisco, California
- Employees
- 501–1000
- Business Model
- B2B
- Website
- standardbio.com
- Type
- Public
About
Standard BioTools Inc. (NASDAQ: LAB), formerly known as Fluidigm Corp., is a life science tools company headquartered in South San Francisco, California, that delivers leading proteomic and multi-omic solutions enabling researchers to discover unique biological insights not accessible by other technologies. The company's core franchises span mass cytometry (CyTOF systems), imaging mass cytometry (Hyperion), and microfluidics-based genomics (Biomark). These platforms support high-parameter single-cell proteomics, spatial proteomics, NGS library preparation, genotyping, gene expression analysis, and pathogen detection. Standard BioTools serves academic, government, pharmaceutical, biotechnology, and clinical research laboratories worldwide. In 2026, the company announced a merger agreement with Treeline Biosciences.
Summary
Standard BioTools is a Manufacturing company based in South San Francisco, United States.
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...

Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.

Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...